NYSE tested Avalanche technology for a year, AVAX surges
NYSE spent a year testing the Avalanche blockchain for tokenised stock trading, and AVAX jumped nearly 16%. European investors already have access via a MiCA-compliant white paper, regardless of NYSE's choice.
The New York Stock Exchange spent the past year testing Avalanche's blockchain for a platform meant to trade and settle tokenised US stocks and ETFs. Ava Labs president Charley Cooper disclosed this on 18 September. AVAX jumped nearly 16% the same day. For European investors, access doesn't change: AVAX already has a MiCA-compliant white paper and trades freely on licensed EU platforms — whether or not NYSE ends up choosing Avalanche.
What NYSE actually tested
Charley Cooper, president of Ava Labs (the developer behind Avalanche), said NYSE has spent the past year testing Avalanche technology and that the exchange "pressed us hard on the project's economics." He called the relationship "close" but wouldn't confirm a final selection: "I leave it to the NYSE guys to talk publicly about where they are in the whole process" (source: The Block, 18 September 2026).
Michael Blaugrund, head of strategic initiatives at ICE (NYSE's parent), independently confirmed his team was "very engaged" during the evaluation and that "Avalanche checks a lot of those boxes for us" (source: The Block, 18 September 2026). KuCoin independently confirms the core of the story: NYSE has been testing the technology for over a year for infrastructure meant to trade and settle tokenised US stocks and ETFs, potentially around the clock (source: KuCoin, 18 September 2026).
Important: no winner has been named. NYSE already works with tZERO as a design partner, but has not finalised a blockchain choice for the settlement platform.
Why this matters alongside this week's SEC news
This test stands apart from, but connects to, the "Innovation Exemption" the SEC approved on 17 September for onchain trading of tokenised shares (see: SEC opens onchain stock trading, bitcoin hits $81,000). An exchange like NYSE testing a blockchain for exactly this kind of trading shows that tokenisation infrastructure is being built seriously — not only by startups, but by the established US stock exchange itself.
What it means for European AVAX holders
Here's where the contrast with last week's SEC story matters: that exemption applied only in the US and gave EU investors no access. AVAX itself is different. Avalanche already has a MiCA-compliant white paper registered — issuer LCX filed it with its national competent authority, which notified ESMA, as MiCA's admission-to-trading process requires (source: LCX, AVAX white paper v1.1). That means AVAX can already be legally offered on licensed platforms within the EU, regardless of whether NYSE ultimately picks Avalanche.
In other words: a European investor already holding AVAX on a MiCA-licensed platform already has exposure to whatever comes of the NYSE evaluation. There's no separate US access barrier, unlike with the tokenised shares under the Innovation Exemption.
The catch: still no decision
NYSE has confirmed nothing final. The evaluation could still end with a different blockchain, a combination of technologies, or even a delay of the whole tokenisation plan. AVAX's price gain is running ahead of a decision that hasn't been made — anyone buying on this news alone is buying an expectation, not a confirmed contract.
Frequently asked questions
Is AVAX legal to buy within the EU?
Yes. Avalanche has a registered MiCA-compliant white paper, which allows licensed EU platforms to offer AVAX.
Has NYSE definitively chosen Avalanche for its tokenisation platform?
No. Ava Labs only confirms NYSE tested it for a year; no final choice has been announced.
What's the difference with this week's SEC Innovation Exemption?
The Innovation Exemption is a US exemption for trading tokenised shares, with no effect outside the US. The NYSE test of Avalanche is about the underlying technology such a platform could run on — and, via AVAX itself, already has a legal route into the EU.
Why did AVAX rise on this news?
Because an established exchange like NYSE seriously investing time and money in testing Avalanche read to investors as a signal of growing institutional interest — even without a final decision.
Sources, checked 21 September 2026:
- The Block — Ava Labs president says NYSE spent a year testing Avalanche technology, 18 Sep 2026
- KuCoin — NYSE Has Tested Avalanche Technology for Over a Year, 18 Sep 2026
- LCX — Avalanche (AVAX) MiCA White Paper, accessed 21 Sep 2026